Literature DB >> 18576316

Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.

Ram Kumar Chowdary Venigalla1, Theresa Tretter, Stefan Krienke, Regina Max, Volker Eckstein, Norbert Blank, Christoph Fiehn, Anthony Dick Ho, Hanns-Martin Lorenz.   

Abstract

OBJECTIVE: CD4+,CD25high regulatory T (Treg) cells play a crucial role in the maintenance of self tolerance and prevention of organ-specific autoimmunity. The presence of many in vivo-preactivated CD4+,CD25++ T cells in patients with systemic lupus erythematosus (SLE) poses a difficulty in discriminating CD25++ activated T cells from CD25high Treg cells. To overcome this problem, we analyzed the phenotype and function of CD4+,CD25high,CD127(-/low) natural Treg (nTreg) cells isolated from the peripheral blood of patients with SLE.
METHODS: CD4+,CD25high,CD127(-/low) nTreg cells and CD4+,CD25- responder T (Tresp) cells from patients with SLE and normal donors were separated by fluorescence-activated cell sorting. Cell proliferation was quantified by 3H-thymidine incorporation, and immunophenotyping of the cells was done using FACScan.
RESULTS: Comparable percentages of CD4+,CD25high,FoxP3+ T cells were observed in patients with SLE and normal donors. Proliferation of SLE nTreg cells sorted into the subset CD4+,CD25high,CD127(-/low) was significantly decreased compared with that of SLE nTreg cells sorted into the subset CD4+,CD25high (mean +/- SEM 2,223 +/- 351 counts per minute versus 9,104 +/- 1,720 cpm, respectively), while in normal donors, these values were 802 +/- 177 cpm and 2,028 +/- 548 cpm, respectively, confirming that effector cell contamination was reduced. Notably, the suppressive activity of nTreg cells was intact in all groups. However, CD4+,CD25- Tresp cells isolated from patients with active SLE were significantly less sensitive than those from patients with inactive SLE to the suppressive function of autologous or normal donor CD4+,CD25high,CD127(-/low) nTreg cells. Furthermore, a significant inverse correlation was observed between the extent of T cell regulation in suppressor assays and the level of lupus disease activity.
CONCLUSION: This study is the first to show that, in human SLE, impaired sensitivity of Tresp cells to the suppressive effects of a comparably functional, highly purified nTreg cell population leads to a defective suppression of T cell proliferation in active SLE. Studies aiming to define the mechanisms leading to Tresp cell resistance might help in the development of highly specific, alternative immunotherapeutic tools for the control of systemic autoimmune diseases such as SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18576316     DOI: 10.1002/art.23556

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  86 in total

1.  Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.

Authors:  Kathryn Paunicka; Peter W Chen; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2011-12-16       Impact factor: 4.962

Review 2.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

3.  Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Authors:  J Baraut; E I Grigore; F Jean-Louis; S H Khelifa; C Durand; F Verrecchia; D Farge; L Michel
Journal:  Bone Marrow Transplant       Date:  2013-12-23       Impact factor: 5.483

Review 4.  Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.

Authors:  Matthew A Dale; Melissa K Ruhlman; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

5.  OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.

Authors:  Clément Jacquemin; Jean-François Augusto; Marc Scherlinger; Noémie Gensous; Edouard Forcade; Isabelle Douchet; Emeline Levionnois; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Julien Seneschal; Lionel Couzi; Jean-Luc Pellegrin; Jean-François Viallard; Thierry Schaeverbeke; Virginia Pascual; Cécile Contin-Bordes; Patrick Blanco
Journal:  JCI Insight       Date:  2018-12-20

Review 6.  TREG-cell therapies for autoimmune rheumatic diseases.

Authors:  Makoto Miyara; Yoshinaga Ito; Shimon Sakaguchi
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

Review 7.  Functional defect in regulatory T cells in myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Julie Rowin; Qin Li Jiang; Jian Rong Sheng; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

8.  LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127.

Authors:  Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

9.  The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Authors:  Anya Schneider; Mary Rieck; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Jane H Buckner
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.

Authors:  Nalini Kumar Vudattu; Sharon Kuhlmann-Berenzon; Mohsen Khademi; Vicki Seyfert; Thomas Olsson; Markus J Maeurer
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.